Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma
BACKGROUND: The novel disease caused by the new coronavirus SARS-CoV-2 has caused an unprecedented global pandemic. Care providers of asthmatic children are increasingly con-cerned; as viral infections are one of the primary triggers of asthma flare-up. However, the effect of SARS-CoV-2 as well as the generated worldwide lockdown on asthmatic children is unknown.
OBJECTIVE: The aim of this study was to analyze the effects of pandemic SARS-CoV-2 in pediat-ric asthma control.
MATERIAL AND METHODS: A retrospective, open, transversal study was performed at five ter-tiary hospitals. Recruited patients were aged <18 years and had physician-diagnosed asthma. Information regarding the 2019 and 2020 seasons were provided.
RESULTS: Data were collected from 107 children (age range: 3-18 years, mean age: 12 years). Well-controlled asthma was observed in 58 (54.2%) patients in 2020 versus 30 (28%) in 2019, and 15 (14%) patients had poorly controlled asthma in 2020 versus 28 (26.2%) in 2019. In 2020, a decrease in exacerbations caused by allergies to pollen, dust mites, molds, and through other causes not related to SARS-CoV-2 infection was observed. An increase in exacerbations was observed due to animal dander, stress, physical exercise, and SARSCoV-2 infection. Children had a reduced need for asthma-controlling medication, made fewer visits to healthcare providers and had lesser need of treatment with oral corticosteroids if compared with the same season of 2019.
CONCLUSION: Pediatric asthma control improved, the need for controller medication declined, and fewer visits to healthcare providers were made during the pandemic if compared with the 2019 season.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Allergologia et immunopathologia - 50(2022), 1 vom: 25., Seite 99-103 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sánchez-García, Silvia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Asthma control |
|---|
| Anmerkungen: |
Date Completed 05.01.2022 Date Revised 29.04.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.15586/aei.v50i1.492 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335014607 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335014607 | ||
| 003 | DE-627 | ||
| 005 | 20231225224920.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15586/aei.v50i1.492 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1116.xml |
| 035 | |a (DE-627)NLM335014607 | ||
| 035 | |a (NLM)34965644 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sánchez-García, Silvia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2022 | ||
| 500 | |a Date Revised 29.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: The novel disease caused by the new coronavirus SARS-CoV-2 has caused an unprecedented global pandemic. Care providers of asthmatic children are increasingly con-cerned; as viral infections are one of the primary triggers of asthma flare-up. However, the effect of SARS-CoV-2 as well as the generated worldwide lockdown on asthmatic children is unknown | ||
| 520 | |a OBJECTIVE: The aim of this study was to analyze the effects of pandemic SARS-CoV-2 in pediat-ric asthma control | ||
| 520 | |a MATERIAL AND METHODS: A retrospective, open, transversal study was performed at five ter-tiary hospitals. Recruited patients were aged <18 years and had physician-diagnosed asthma. Information regarding the 2019 and 2020 seasons were provided | ||
| 520 | |a RESULTS: Data were collected from 107 children (age range: 3-18 years, mean age: 12 years). Well-controlled asthma was observed in 58 (54.2%) patients in 2020 versus 30 (28%) in 2019, and 15 (14%) patients had poorly controlled asthma in 2020 versus 28 (26.2%) in 2019. In 2020, a decrease in exacerbations caused by allergies to pollen, dust mites, molds, and through other causes not related to SARS-CoV-2 infection was observed. An increase in exacerbations was observed due to animal dander, stress, physical exercise, and SARSCoV-2 infection. Children had a reduced need for asthma-controlling medication, made fewer visits to healthcare providers and had lesser need of treatment with oral corticosteroids if compared with the same season of 2019 | ||
| 520 | |a CONCLUSION: Pediatric asthma control improved, the need for controller medication declined, and fewer visits to healthcare providers were made during the pandemic if compared with the 2019 season | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a asthma control | |
| 650 | 4 | |a asthma severity | |
| 650 | 4 | |a pediatric asthma | |
| 700 | 1 | |a Ruiz-Hornillos, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Bernaola, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Habernau-Mena, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Lasa, Eva María |e verfasserin |4 aut | |
| 700 | 1 | |a Contreras, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Candón-Morillo, Rocío |e verfasserin |4 aut | |
| 700 | 1 | |a Antón-Rodríguez, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Escudero, Carmelo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergologia et immunopathologia |d 1973 |g 50(2022), 1 vom: 25., Seite 99-103 |w (DE-627)NLM000045926 |x 1578-1267 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2022 |g number:1 |g day:25 |g pages:99-103 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.15586/aei.v50i1.492 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2022 |e 1 |b 25 |h 99-103 | ||